AbbVie, a global biopharmaceutical company, has announced the launch of its ovarian cancer therapy, Elahere, in the United Kingdom. The treatment will be priced at the...
American Diversified Holdings Corporation (ADHC) has announced significant advancements in the development of its innovative GlucoGuard system, following a detailed update from its partner, Arete Biosciences,...